| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 15, 2018 | 79.80 | 79.80 | 74.00 | 74.00 | 36,220 |
| Aug 14, 2018 | 76.46 | 80.00 | 76.46 | 80.00 | 45,616 |
| Aug 13, 2018 | 80.00 | 80.02 | 74.40 | 74.40 | 13,720 |
| Aug 10, 2018 | 78.02 | 79.00 | 76.80 | 77.90 | 1,336 |
| Aug 9, 2018 | 76.52 | 76.52 | 76.52 | 76.20 | 1,588 |
| Name | Circassia Pharmaceuticals | Epic | CIR |
|---|---|---|---|
| ISIN | GB00BJVD3B28 | Currency | GBX |
| Type | Equity | Trading Segment | SSMM |
| Record Status | Active | Trading Status | Regular Trading |
| Industry | Health Care | Sector | Pharmaceuticals & Biotechnology |
| EMS | 3,000 | Prev Close | 74.00 |
| Shares in Issue (m) | 357.19 | Market Cap (£m) | 264.32 |
| PE Ratio | -2.39 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -31.00 | EPS Growth (%) | 35.42 |
| PEG | -0.07 | DPS Growth (%) | n/a |
| ROCE | -30.57 | Net Gearing | 33.08 |
| Quick Ratio | 2.76 | Current Ratio | 2.92 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 13 Aug | Peel Hunt | Hold | 75.95 | 120.00 | - | Reiterates |
| 01 Aug | Peel Hunt | Hold | 75.95 | 120.00 | - | Reiterates |
| 03 Jul | Peel Hunt | Hold | 75.95 | 120.00 | - | Reiterates |
| 01 Jun | Peel Hunt | Hold | 75.95 | 120.00 | - | Reiterates |
| 31 May | Peel Hunt | Hold | 75.95 | 120.00 | - | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 17 Jul 2017 | Steven Harris | Exercise | 535,375 @ 0.08p | £428.30 |
| 18 Sep 2015 | Charles Swingland | Sell | 1,230,000 @ 318.24p | £3,914,352.00 |
| 18 Sep 2015 | Charles Swingland | Sell | 9,000 @ 318.72p | £28,684.80 |
| 18 Sep 2015 | Charles Swingland | Sell | 754,548 @ 320.24p | £2,416,364.52 |
| 27 Mar 2014 | Dr Rod Hafner | Exercise | 212,375 @ 0.08p | £169.90 |
